Shares of Liberty Health Sciences Inc (OTCMKTS:LHSIF) have started to move back to the upside after a successful hold of key support in the $0.25/share area in late March. Now, the stock is flirting with a break above its 200-day moving average, and just announced the expansion to its award-winning brand portfolio of premium products that are available at all of its locations in Florida.
According to the release, Liberty launched its Liberty Health Sciences Shake brand to join its expanded and current portfolio that includes innovative cannabis products and formats, including premium flower, CBD, topicals, tinctures, extract and vape products. Liberty recently introduced Clarity Brands www.claritybrands.life that includes oil derived products on cartridges and G Pen pods and is available in all of its stores. The Company has also recently introduced the all-new Papa’s Herb classic 510 Cartridge pen to its Papa’s Herb line up that has proven to be a popular new item in all of the dispensaries. In addition, Liberty has extended its popular offering of G Pen devices to include Roam, Elite, Connect, Gio, Pro, and Nova.
Liberty Health Sciences Inc (OTCMKTS:LHSIF) frames itself as a company that engages in the production and distribution of medical cannabis primarily in the State of Florida.
It has a strategic partnership with Veterans Cannabis Project to support various research projects focused on the treatment of service related trauma with cannabis derived products; and partnership with AdaViv Inc. to enhance production of cannabis.
The company is headquartered in Toronto, Canada.
Liberty Health Sciences was established to own and operate medical marijuana licenses in the United States. To date, the company owns one of 14 licenses issued in the state of Florida as well as 50.1% interest in a provisional processing license and a provisional dispensary license, both in Ohio. Liberty has also made an investment in a provisional medical license in the Commonwealth of Massachusetts.
According to company materials, “Liberty is the cannabis provider committed to providing a trusted, high quality cannabis experience based on our genuine care for all cannabis users and a focus on operational excellence from seed to sale and beyond. Liberty’s measured approach to expansion opportunities maximizes returns to shareholders, while keeping consumers’ well-being at the forefront of what we do.”
Find out when $LHSIF reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
As noted above, LHSIF just announced the expansion to its award-winning brand portfolio of premium products that are available at all of its locations in Florida.
The chart shows 27% during the past month in terms of shareholder gains in the name. What’s more, the name has benefitted from a jump in recent trading volume to the tune of 49% beyond its prior sustained average level.
“We are always looking for ways to enhance our product offerings and find ways to better serve our patient’s needs,” said Victor Mancebo, Chief Executive Officer of Liberty. “Our passion and determination is to provide accessibility of best in class products at valued prices, especially during these challenging times. We are excited to grow our offering and provide the right cannabis derived medical options at a time when people need affordable ways to maintain their wellness and continue to practice social distancing.”
Now commanding a market cap of $132M, LHSIF has a significant war chest ($28.5M) of cash on the books, which is balanced by about $21.7M in total current liabilities. One should also note that debt has been growing over recent quarters. LHSIF is pulling in trailing 12-month revenues of $35.7M. In addition, the company is seeing major top-line growth, with y/y quarterly revenues growing at 408.3%. This may be a very interesting story and we will look forward to updating it again soon. Sign-up for continuing coverage on shares of $LHSIF stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in $LHSIF, either long or short, and we have not been compensated for this article.